Skip to content
10-Q

Quarterly Report

GENEREX BIOTECHNOLOGY CORP

0001607062-21-000056

← back to feed
Filed
Mar 17, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Mar 15, 2021 114.94M sh
Shares Diluted Q2 2021 · Jan 31, 2021 110.12M sh
Shares Diluted Q2 2021 · Jan 31, 2021 103.5M sh
Shares Diluted Q2 2021 · Jan 31, 2020 65.6M sh
Shares Diluted Q2 2021 · Jan 31, 2020 67.77M sh
Capex Q2 2021 · Jan 31, 2021 $0
Capex Q2 2021 · Jan 31, 2020 $4.62K
Operating Cash Flow Q2 2021 · Jan 31, 2021 −$2.32M
Operating Cash Flow restated Q2 2021 · Jan 31, 2020 −$4.62M
Short Term Debt Q2 2021 · Jan 31, 2021 $10.06M
Short Term Debt Q2 2021 · Jul 31, 2020 $10.67M
Cash And Equivalents Q2 2021 · Jan 31, 2021 $596.03K
Cash And Equivalents Q2 2021 · Jul 31, 2020 $15.45K
Cash And Equivalents Q2 2021 · Jan 31, 2020 $269.07K
Cash And Equivalents Q2 2021 · Jul 31, 2019 $298.49K
Stockholders Equity Q2 2021 · Jan 31, 2021 −$59.19M
Stockholders Equity Q2 2021 · Oct 31, 2020 −$36.11M
Stockholders Equity Q2 2021 · Jul 31, 2020 −$11.96M
Stockholders Equity Q2 2021 · Jan 31, 2020 −$50.53K
Stockholders Equity Q2 2021 · Oct 31, 2019 $4.87M
Stockholders Equity Q2 2021 · Jul 31, 2019 $7.67M
Current Liabilities Q2 2021 · Jan 31, 2021 $59.69M
Current Liabilities Q2 2021 · Jul 31, 2020 $41.37M
Total Liabilities Q2 2021 · Jan 31, 2021 $100.62M
Total Liabilities Q2 2021 · Jul 31, 2020 $53.27M
Current Assets Q2 2021 · Jan 31, 2021 $1.77M
Current Assets Q2 2021 · Jul 31, 2020 $1.25M
Total Assets Q2 2021 · Jan 31, 2021 $45.51M
Total Assets Q2 2021 · Jul 31, 2020 $45.38M
Eps Diluted Q2 2021 · Jan 31, 2021 −$0.22
Eps Diluted Q2 2021 · Jan 31, 2021 −$0.34
Eps Diluted Q2 2021 · Jan 31, 2020 −$0.11
Eps Diluted Q2 2021 · Jan 31, 2020 −$0.24
Eps Basic Q2 2021 · Jan 31, 2021 −$0.22
Eps Basic Q2 2021 · Jan 31, 2021 −$0.34
Eps Basic Q2 2021 · Jan 31, 2020 −$0.11
Eps Basic Q2 2021 · Jan 31, 2020 −$0.24
Sga Expense Q2 2021 · Jan 31, 2021 $6.91M
Sga Expense Q2 2021 · Jan 31, 2021 $19.92M
Sga Expense Q2 2021 · Jan 31, 2020 $4.65M
Sga Expense Q2 2021 · Jan 31, 2020 $9.43M
Rd Expense Q2 2021 · Jan 31, 2021 $1.56M
Rd Expense Q2 2021 · Jan 31, 2021 $2.73M
Rd Expense Q2 2021 · Jan 31, 2020 $599.84K
Rd Expense Q2 2021 · Jan 31, 2020 $938.57K
Net Income Q2 2021 · Jan 31, 2021 −$24.41M
Net Income Q2 2021 · Jan 31, 2021 −$35.4M
Net Income Q2 2021 · Jan 31, 2020 −$7.28M
Net Income Q2 2021 · Jan 31, 2020 −$16.59M
Operating Income Q2 2021 · Jan 31, 2021 −$8.58M
Operating Income Q2 2021 · Jan 31, 2021 −$22.69M
Operating Income Q2 2021 · Jan 31, 2020 −$4.56M
Operating Income Q2 2021 · Jan 31, 2020 −$9.11M
Gross Profit Q2 2021 · Jan 31, 2021 −$104.98K
Gross Profit Q2 2021 · Jan 31, 2021 −$39.88K
Gross Profit Q2 2021 · Jan 31, 2020 $691.77K
Gross Profit Q2 2021 · Jan 31, 2020 $1.28M
Cost Of Revenue Q2 2021 · Jan 31, 2021 $104.98K
Cost Of Revenue Q2 2021 · Jan 31, 2021 $128.32K
Cost Of Revenue Q2 2021 · Jan 31, 2020 $165.66K
Cost Of Revenue Q2 2021 · Jan 31, 2020 $299.28K
Revenue Q2 2021 · Jan 31, 2021 $0
Revenue Q2 2021 · Jan 31, 2021 $88.44K
Revenue Q2 2021 · Jan 31, 2020 $857.43K
Revenue Q2 2021 · Jan 31, 2020 $1.58M